Pediatric Diffuse Midline Gliomas H3 K27M-Mutant and Non-Histone Mutant Midline High-Grade Gliomas in Neurofibromatosis Type 1 in Comparison With Non-Syndromic Children: A Single-Center Pilot Study-Reference-Cited by-同舟云学术

Pediatric Diffuse Midline Gliomas H3 K27M-Mutant and Non-Histone Mutant Midline High-Grade Gliomas in Neurofibromatosis Type 1 in Comparison With Non-Syndromic Children: A Single-Center Pilot Study

Published:2020-06-03 Issue: Volume:10 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Garibotto Federica,Madia Francesca,Milanaccio Claudia,Verrico Antonio,Piccardo Arnoldo,Tortora Domenico,Piatelli Gianluca,Diana Maria Cristina,Capra Valeria,Garrè Maria Luisa,Rossi Andrea,Morana Giovanni

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference41 articles.

1. Prevalence of neurofibromatosis 1 in German children at elementary school enrollment;Lammert;Arch Dermatol.,2005

2. Molecular genetics of neurofibromatosis type 1 (NF1);Shen;J Med Genet.,1996

3. Risk of benign tumours of nervous system, and of malignant neoplasms, in people with neurofibromatosis: population-based record-linkage study;Seminog;Br J Cancer.,2013

4. Neurofibromatosis type 1 and high-grade tumors of the central nervous system;Rosenfeld;Childs Nerv Syst.,2010

5. Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1): a retrospective study of 104 patients;Guillamo;Brain.,2003

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Characteristics and Prognostic Factors in H3 K27- altered Diffuse Midline Gliomas: A 64 Cases Retrospective Cohort Analysis;2023-09-12

2. High-Grade Gliomas and Cancer Predisposition Syndromes in children and adolescents: Unpacking the Impact through a Single-Center Analysis;2023-08-10

3. H3 K27M-Altered Diffuse Midline Gliomas: A Review;Indian Journal of Neurosurgery;2023-07-26

4. Imaging features associated with H3 K27-altered and H3 G34-mutant gliomas: a narrative systematic review;Cancer Imaging;2022-11-17

5. Construction of a cuproptosis-related lncRNA signature as a novel prognostic model for pancreatic adenocarcinoma;2022-10-24